Cytek Biosciences (CTKB) has introduced an Enhanced Small Particle, or ESP, Detection Option for its Cytek Aurora CS system. This is the first ...

Cytek Biosciences, Inc. ( (CTKB) ) has released its Q3 earnings. Here is a breakdown of the information Cytek Biosciences, Inc. presented to ...

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 6.4% growth forecast ...

Interested parties may access a live and archived webcast of these presentations on the “Investors” section of the company website at: investors.cytekbio.com. Cytek’s products are for ...

Analysts are estimating that Cytek Biosciences will report an earnings per share (EPS) of $0.00. The announcement from Cytek Biosciences is eagerly anticipated, with investors seeking news of ...

Cytek Biosciences, Inc. (NASDAQ: CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to break-even earnings per share a ...

In recent trading, Cytek Biosciences Inc (CTKB) stock price has shown some volatility, fluctuating 8.96% over the last five trades and -0.58% over the past 30 trades. This represents a notable shift ...

Thank you for standing by. At this time, I'd like to welcome everyone to the Cytek Biosciences' Third Quarter 2024 Earnings Conference Call. All lines have been placed on mute to prevent any ...

This represents an increase of $0.6 million, despite a cash expenditure of $12.1 million for the repurchase of Cytek shares during the third quarter. Cytek Biosciences reaffirms its 2024 revenue ...

This represents an increase of $0.6 million, despite a cash expenditure of $12.1 million for the repurchase of Cytek shares during the third quarter. Cytek Biosciences reaffirms its 2024 revenue ...